Paediatric anaesthesia & critical care

Association of Enteral Chloral Hydrate with Benzodiazepine Exposure and Delirium After Pediatric Cardiac Surgery: A Retrospective Before-and-After Cohort Study

J Cardiothorac Vasc AnesthPublished Single-center retrospective before-and-after cohort study

Authors' conclusion

Addition of enteral chloral hydrate to a postoperative sedation protocol was associated with reduced benzodiazepine exposure and a lower observed frequency of delirium without statistically significant differences in sedation quality or short-term clinical outcomes. Prospective multicenter studies are warranted to confirm these findings.

Study context

Population
Children who underwent congenital heart surgery with cardiopulmonary bypass, required postoperative mechanical ventilation for more than 24 hours, and received sedation for at least 24 hours; pediatric cardiac intensive care unit of a tertiary referral centerchildren included
Participants
Eighty-six children
Exposure
Chloral hydrate group vs preprotocol group
Outcome
Cumulative midazolam exposure during the pediatric cardiac intensive care unit stay

Main finding

As reported in the abstract

P = 0.010

Observational data: associations, not effects.

Secondary outcomes

Peak midazolam infusion rates · significantly lower in the chloral hydrate group

P < 0.001

Delirium (observed frequency) · lower observed frequency in the chloral hydrate group

P = 0.015

Sedation quality, pain scores, withdrawal, duration of mechanical ventilation, length of stay in the pediatric cardiac intensive care unit or hospital, mortality

No significant between-group differences

Original publication

Association of Enteral Chloral Hydrate with Benzodiazepine Exposure and Delirium After Pediatric Cardiac Surgery: A Retrospective Before-and-After Cohort Study. J Cardiothorac Vasc Anesth. Published 2 October 2026. doi:10.1053/j.jvca.2026.09.055

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.